About the Event
On July 29th, 2021, we celebrated amazing news regarding our human trial of our HIV Cure Program. The Data and Safety Monitoring Board (DSMB) voted unanimously to continue AGT’s HIV Cure Program without modification after safety analysis of the first participant’s data revealed no adverse effects from the treatment AGT103-T. We are now one step closer to a functional cure for HIV after this critical milestone! We had a wonderful time safely reuniting with our AGT friends and family, and we look forward to celebrating the next milestone with you. Read the full press release, click here.
Subscribe to Our Newsletter
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
